A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer: The ‘LUNGFUL’ Study

SIMPLE SUMMARY: Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases, with few patients carrying driver mutations in the gene encoding for epidermal growth factor receptor (EGFR). Advances in translational research have established EGFR tyrosine kinase inhibitors (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Mountzios, Giannis, Koumarianou, Anna, Bokas, Alexandros, Mavroudis, Dimitrios, Samantas, Epaminondas, Fergadis, Evangelos Georgios, Linardou, Helena, Katsaounis, Panagiotis, Athanasiadis, Elias, Karamouzis, Michalis V., Pentheroudakis, George, Lampaki, Sofia, Froudarakis, Marios E., Perdikouri, Eleni-Isidora A., Somarakis, Alvertos, Papageorgiou, Foteini, Paparepa, Zoe, Nikolaou, Aristeidis, Syrigos, Konstantinos N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268841/
https://www.ncbi.nlm.nih.gov/pubmed/34202063
http://dx.doi.org/10.3390/cancers13133172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268841/
https://www.ncbi.nlm.nih.gov/pubmed/34202063
http://dx.doi.org/10.3390/cancers13133172

Ejemplares similares